Technology

Navidea Biopharmaceuticals

$2.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.36%) Today
+$0.12 (+5.38%) As of 12:42 AM UTC after-hours

Why Robinhood?

You can buy or sell NAVB and other stocks, options, and ETFs commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH. The listed name for NAVB is Navidea Biopharmaceuticals Inc.

CEO
Jed Andrew Latkin
Employees
17
Headquarters
Dublin, Ohio
Founded
1983
Market Cap
59.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
319.22K
High Today
$2.23
Low Today
$2.15
Open Price
$2.20
Volume
171.24K
52 Week High
$5.36
52 Week Low
$0.63

Collections

NAVB Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, After Hours

You May Also Like

NID
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure